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ABSTRACT
News about the first baby born after a mitochondrial replacement tech-
nique (MRT; specifically maternal spindle transfer) broke on September
27, 2016 and, in a matter of hours, went global. Of special interest was the
fact that the mitochondrial replacement procedure happened in Mexico.
Oneof the scientists behind thisworld firstwas quoted as having said that he
and his teamwent toMexico to carry out the procedure because, inMexico,
there are no rules. In this paper, we explore Mexico’s rule of law in relation
to mitochondrial replacement techniques and show that, in fact, certain in-
stances ofMRTs are prohibited at the federal level andothers are prohibited
at the state level. According to our interpretation of the law, the scientists be-
hind this first successful MRT procedure broke federal regulations regard-
ing assisted fertilization research.
KEYWORDS: mitochondrial replacement techniques, mitochondrial re-
placement therapy, mitochondrial donation, maternal spindle transfer,
pronuclear transfer, tri-parenthood, three parent babies, three parent IVF
INTRODUCTION
Newsof the first baby born after amitochondrial replacement technique (MRT; specif-
ically maternal spindle transfer [MST]) broke on September 27, 2016 and, in a matter
C©The Author 2017. Published by Oxford University Press on behalf of Duke University School of Law, Harvard
Law School, Oxford University Press, and Stanford Law School. This is an Open Access article distributed under
the terms of theCreativeCommons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly
cited.
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of hours, went global.1 It was reported that the baby boy had been born to a Jordanian
couple on the April 6, 2016 and was doing well. This biotechnological feat—the first
of its kind in the world—was achieved by a team of scientists led by Dr. John Zhang.
Zhang is the founder/CEO and medical director of the New Hope Fertility Clinic in
NewYorkCity, NY.The Jordanian couple had resorted to Zhang after two of their chil-
dren had died from Leigh’s syndrome2—one at 6 years old and the other at 8 months
old. At the present moment, the technical information we know about this case does
not come from an academic paper; it comes from Zhang’s short conference abstract
and presentation, the statements that he and his team have given to the media, and the
media reports from a late-breaking session at the American Society for Reproductive
Medicine 2016 Scientific Congress.3 One of the things we know, and that is relevant
for this paper, is that five oocytes were subject toMST and later fertilized via intracyto-
plasmic sperm injection. One embryo did not develop to the blastocyst stage, whereas
four embryos did develop to the blastocyst stage. Of these four embryos, three were
aneuploid and one was euploid. Euploidy is the presence of a normal complement of
chromosomes. Aneuploidy is the presence of an abnormal number of chromosomes.
MRTs are only explicitly legal in the UK.4 Last year, after a long period of public
consultation, both houses of parliament approved regulations put forward by the De-
partmentofHealth, and these came into forceonOctober 29, 2015.5 Inorder forMRTs
to be carried out in the UK lawfully, clinics or centers must apply for and be granted a
license, for each proposed procedure, from the Human Fertilisation and Embryology
Authority. In the USA, this topic has been debated by a National Academy of Sciences
panel, which recently published its recommendations in the Ethical and Social Policy
Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochon-
drial DNA Diseases.6 Although the panel asserted that MRTs are, in principle, ethically
acceptable, within certain limitations, Congress, through a federal spending bill, has ef-
fectively blocked them by prohibiting the FDA from considering applications to carry
out these techniques:
1 Jessica Hamzelou, World’s First Baby Born With New ‘3 Parent’ Technique New Scientist (2016), https://
www.newscientist.com/article/2107219-exclusive-worlds-first-baby-born-with-new-3-parent-technique/
(accessed Oct. 3, 2016).
2 Leigh’s syndrome is a devastating neurological disorder. It is characterized by the degeneration of the central
nervous system,which causes psychomotor regression and loss ofmental abilities.Most patients die a fewyears
after its diagnosis.
3 John Zhang et al., First Live Birth Using Human Oocytes Reconstituted by Spindle Nuclear Transfer
for Mitochondrial DNA Mutation Causing Leigh Syndrome, 106 FERTIL. STERIL. e375–e376 (2016);
Kate Johnson, First Spindle Nuclear Transfer Baby Has Low Mutant DNA Load Medscape (2016),
http://www.medscape.com/viewarticle/870766 (accessedDec. 7, 2016); Judge Science onMerit, Not Assump-
tions, 539NATURENEWS139 (2016);Medscape,Dr JohnZhang SpeakingAt #artworldcongress About BabyBorn
With DNA from 3 People (2016), https://www.periscope.tv/Medscape/1BRJjANLwVgGw# (accessed Dec.
7, 2016).
4 James Gallagher, UK Approves Three-Person Babies, BBC NEWS, Feb. 24, 2015, http://www.bbc.
co.uk/news/health-31594856 (accessed Oct. 3, 2016).
5 HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY, THE HUMAN FERTILISATION AND EM-
BRYOLOGY (MITOCHONDRIAL DONATION) REGULATIONS 2015 (2015), http://www.legislation.gov.uk/
uksi/2015/572/pdfs/uksi 20150572 en.pdf (accessed Oct. 5, 2016).
6 INSTITUTEOFMEDICINEOFTHENATIONALACADEMIES,MITOCHONDRIALREPLACEMENTTECHNIQUES:ETHICAL,
SOCIAL, AND POLICY CONSIDERATIONS (2016), http://www.nap.edu/21871 (accessedMar. 3, 2016).
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None of the funds made available by this Act may be used to notify a sponsor or oth-
erwise acknowledge receipt of a submission for an exemption for investigational use of a
drug or biological product under section 505(i) of the Federal Food,Drug, andCosmetic
Act (21 U.S.C. 355(i)) or section 351(a)(3) of the Public Health Service Act (42 U.S.C.
262(a)(3)) in research in which a human embryo is intentionally created or modified to
include a heritable genetic modification. Any such submission shall be deemed to have
not been received by the Secretary, and the exemption may not go into effect. 7
The former, of course, affects MRTs in the creation of female embryos, as mitochon-
dria are only maternally transmitted (as will become clear next). On the other hand,
the wording of the Bill does not rule out the creation of male embryos, who do not
transmit mitochondria to further generations. Even if this is so, a spokesperson of the
FDA has said that ‘human subject research utilizing genetic modification of embryos
for the prevention of transmission of mitochondrial disease cannot be performed in
the United States in FY [fiscal year] 2016’.8 Thus, MRTs have effectively hit a road
block in the USA.9 Additionally, it is important to bear two things in mind. First, no
US federal legislation explicitly addresses human genetic modification. Second, in the
USA, the Dickey-Wicker Amendment prohibits the use of federal funds for the creation
of human embryos for research, or for research that results in the destruction of human
embryos:
(1) the creation of a human embryo or embryos for research purposes; or
(2) research in which a human embryo or embryos are destroyed, discarded, or
knowingly subjected to risk of injury or death greater than that allowed for
research on fetuses in utero under 45 C.F.R. 46.208(a)(2) and 42 U.S.C.
289g(b).10
It seems that all of these regulatory issues, in addition to the FDA’s actions when a
‘similar’ procedure (cytoplasmic transfer11) was conducted in the USA in the recent
past, prompted Zhang to carry out the procedure in Mexico.12 Why Mexico? Because
the research and clinical practice of assisted reproduction in Mexico is very loosely
7 Charles Dent, TEXT - H.R.2029 - 114th Congress (2015ffi2016): CONSOLIDATED APPROPRIATIONS ACT,
2016 SEC. 749 (2015), https://www.congress.gov/bill/114th-congress/house-bill/2029/text (accessed Oct.
3, 2016).
8 ZACHARYBRENNAN, EXPERTCOMMITTEE:FDASHOULDALLOWMITOCHONDRIALREPLACEMENTTRIALSUNDER
CERTAIN CONDITIONS, REGULATORY AFFAIRS PROFESSIONALS SOCIETY (2016), http://raps.org/Regulatory-
Focus/News/2016/02/03/24245/Expert-Committee-FDA-Should-Allow-Mitochondrial-Replacement-
Trials-Under-Certain-Conditions/ (accessed Oct. 4, 2016).
9 I. Glenn Cohen & Eli Y. Adashi, Preventing Mitochondrial DNA Diseases: One Step Forward, Two Steps Back,
316 JAMA 273–274 (2016).
10 Bob Livingston, H.R.2880, 104th Congress (1995ffi1996): BALANCEDBUDGETDOWNPAYMENTACT, I Sec. 128
(1996), https://www.congress.gov/bill/104th-congress/house-bill/02880 (accessed Oct. 3, 2016).
11 In cytoplasmic transfer, cytoplasm from a donor egg is transferred into a second egg tomake up for a presump-
tive ‘ooplasmic deficiency’. This technique was indented to help women who had experienced repeated poor
embryo development and implantation failure. Jason A. Barritt et al., Cytoplasmic Transfer in Assisted Repro-
duction, 7 HUM. REPROD.UPDATE 428–435 (2001);MartinH. Johnson, Setting the Record Straight, 33 REPROD.
BIOMED. ONLINE 657–658 (2016).
12 Charlotte Pritchard, The Girl With Three Biological Parents, BBC NEWS, Sept. 1, 2004, http://www.
bbc.co.uk/news/magazine-28986843 (accessed Oct. 14, 2016).
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regulated, if at all, and because Zhang’s fertility clinic has two branches there: one in the
State ofMexico City and the other in the city of Guadalajara, within the state of Jalisco.
The procedure was carried out in the Guadalajara branch. Unfortunately, Zhang was
quoted in the publication that broke the news as stating that he and his team went to
Mexico because, inMexico, ‘there are no rules’.13 Zhangwasmost likely referring to the
fact that, inMexico,MRTs are neither specifically regulatednor specifically forbidden; but
even if this was his intending meaning, the media has since repeated ad nauseam that,
in Mexico, there are no laws governingMRTs and assisted reproduction.
Against this background, in this paper we set out to examineMRTs in the context of
Mexico’s rule of law. Specifically,we explorewhetherMexican lawprohibits either of the
two MRTs: MST and pronuclear transfer (PNT). This research is important in terms
of regulatory background given that the first successful instance of MST occurred in
Mexico and it is feasible that Zhang’s team—or another team—will consider carrying
out either this procedure or PNT, in Mexico again.14
In the first section of the paper, we present a brief account of mitochondrial DNA
diseases and MRTs (if you are familiar with these topics then you can skip ahead to
the second section).We explain how these techniques are carried out and describe two
important characteristics of them. In the second section, we explore Mexico’s rule of
law in regard to MRTs. As stated above, we descriptively examine the legal status of
MST and PNT.15 First, we very briefly describeMexico’s political composition and ex-
amine whether Mexico’s highest national law, the Political Constitution of the United
Mexican States (hereafter the Federal Constitution), specifically protects life from the
moment of conception or fertilization.16 Secondly, we investigate the legality ofMRTs
from the perspective of federal laws.Thirdly, we identify those states inwhich local laws
13 Hamzelou, supra note 1.
14 Two things bear noticing. First, many media headlines have claimed that the baby born after MST was
the first baby to have been intentionally produced with genetic material from three persons. Though
this makes for a catchy headline, children were produced with genetic material from three persons in
the late 1990s after ooplasmic transfer. C. A. Brenner et al., Mitochondrial DNA Heteroplasmy After Hu-
man Ooplasmic Transplantation, 74 FERTIL. STERIL. 573–578 (2000). Second, and most important, af-
ter this paper was accepted for publication Alejandro Chavez-Badiola, the director of New Hope Fertil-
ity Center in Mexico, announced that they are planning to use MST at least 20 times in the first half of
2017. Michael Le Page, Mexico Clinic Plans 20 ‘Three-Parent’ Babies in 2017 New Scientist (2016), https://
www.newscientist.com/article/2115731-exclusive-mexico-clinic-plans-20-three-parent-babies-in-2017/ (ac-
cessed Dec. 12, 2016).
15 Although it is an important topic, in this paper we will not discuss the legal status of surrogacy inMexico or its
regulation through different state level civil codes—statutory law—in places such as Tabasco and Sinaloa.
16 Mexican law does not differentiate between ‘conception’ and ‘fertilization’ and most of the times these
concepts are used interchangeably. Even when this is the case, in a 2012 ruling—Artavia Murillo
et al. (‘In Vitro Fertilization’) v. Costa Rica—the Inter-American Court of Human Rights clarified
what should be understood for conception: ‘the [Inter-American] Court [of Human Rights] under-
stands the word “conception” from the moment at which implantation occurs’ Inter-American Court
of Human Rights, Case of Artavia Murillo et al. (‘In vitro fertilization’) v. Costa Rica, 57 (2012),
http://www.corteidh.or.cr/docs/casos/articulos/seriec 257 ing.pdf (accessed Jun. 12, 2016). In this
paper, we follow the Inter-American Court on Human Rights’ position regarding ‘conception’. We
do this because in Mexican law the jurisprudences of the Inter-American Court of Human Rights are
binding—when Mexico is not part of the judgment—when they give more protections to the person
than the Mexican law. SUPREMA CORTE DE JUSTICIA DE LA NACIO´N, SESIO´N PU´BLICA NU´M. 89 ORDINARIA
(2013), https://www.scjn.gob.mx/sites/default/files/actas-sesiones-publicas/documento/2016-11-15/
89%20-%203%20DE%20SEPTIEMBRE%20DE%202013 0.pdf (accessed Oct. 4, 2016). For an analysis of
how the jurisprudences of the Inter-American Court of Human Rights have, historically, interacted with the
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protect human life from the point of conception and fertilization, and investigate how
MRTs interact with such local laws. We pay particular attention to the state of Jalisco,
given that it was there that the MST was carried out. Fourthly, we examine MRTs in
termsofMexican laws regulating bothhumangenomemodification andhumangenetic
engineering.
In the third section of the paper, the conclusion, we briefly present our main points
and explore how Zhang’s team’s actions have affected the assisted reproduction de-
bate in Mexico. Specifically, we discuss how their actions have helped those who wish
to pass federal legislation to prohibit MRTs, and that would restrict access to assisted
reproduction.
Before moving to the next section, we clarify that this paper does not engage with
the ethics of MRTs17 or how they should be regulated on an international level.18
Mexican law, see Sandra Carrizosa-Guzma´n,Alcance de la Jurisprudencia de la Corte Interamericana de Derechos
Humanos en Me´xico: Reflexiones en torno a la proteccio´n de la Salud, in LA NORMA CONSTITUCIONAL MEXICANA,
PARADIGMA DE TRANSFORMACIO´N SOCIAL. OBRA EN HOMENAJE A LOS CUARENTA AN¨OS DE VIDA ACADE´MICA DEL
DOCTORMARIANO PALACIOS ALCOCER 71–96 (Mariana Leoba Castan˜eda Rivas, et al. ed., 2014).
17 On identity issues, see Franc¸oise Baylis,The Ethics of Creating Children withThree Genetic Parents, 26 REPROD.
BIOMED. ONLINE 531–534 (2013); Anthony Wrigley, Stephen Wilkinson & John B. Appleby,Mitochondrial
Replacement: Ethics and Identity, 29 BIOETHICS 631–638 (2015); S. Matthew Liao, Do Mitochondrial Replace-
ment Techniques Affect Qualitative or Numerical Identity?, 31 BIOETHICS 20–26 (2017). On transgenerational
health risks, see John B. Appleby,The Ethical Challenges of the Clinical Introduction of Mitochondrial Replace-
ment Techniques, 18 MED. HEALTH CARE & PHILOS. 501–514 (2015); Baylis, id. Annelien L. Bredenoord et
al.,Avoiding Transgenerational Risks ofMitochondrial DNADisorders: AMorally Acceptable Reason for Sex Selec-
tion?, 25 HUM. REPROD. 1354–1360 (2010); Martin H. Johnson, Tri-parenthood—A Simply Misleading Term
or an EthicallyMisguidedApproach?, 26REPROD.BIOMED.ONLINE 516–519 (2013).On the disclosure ofMRT
conception, see John B. Appleby, Should Mitochondrial Donation Be Anonymous?, J. MED. & PHILOS. (2016);
Appleby (2015), ibid. Reuven Brandt,Mitochondrial Donation and “The Right to Know,” 42 J. MED. 678–684
(2016); InmaculadadeMelo-Martin,When theMilk ofHumanKindnessBecomes aLuxury (andUntested)Good.
A Reply to Harris’ Unconditional Embrace of Mitochondrial Replacement Techniques, CAMB. Q. HEALTHCARE
ETHICS (2017); John Harris, How To Welcome New Technologies: Some Comments on Inmaculada De Melo-
Martin, CAMB. Q. HEALTHCARE ETHICS (2017); John Harris, Germline Modification and the Burden of Human
Existence, 25 CAMB. Q.HEALTHCARE ETHICS 6–18 (2016); JohnHarris,GermlineManipulation and Our Future
Worlds, 15AM.J.BIOETHICS 30–34 (2015);Ce´sarPalacios-Gonza´lez,ResourceAllocation,Treatment,Disclosure,
and Mitochondrial Replacement Techniques: Some Comments on de Melo-Martin and Harris, CAMB. Q. HEALTH-
CARE ETHICS (2017); Monika W. Piotrowska,Why is an Egg Donor a Genetic Parent, But Not a Mitochondrial
Donor?, CAMB. Q. HEALTHCARE ETHICS (2017). On genealogical ancestry, see Baylis, supra note 17; Ce´sar
Palacios-Gonza´lez,Mitochondrial Replacement Techniques: Egg Donation, Genealogy and Eugenics, 34 MONASH
BIOETHICS REV. 37–51 (2016). On first in-human use, see Annelien L. Bredenoord & Peter Braude, Ethics of
Mitochondrial Gene Replacement: From Bench to Bedside, 341 BMJ c6021 (2010); INSTITUTE OF MEDICINE OF
THE NATIONAL ACADEMIES, supra note 6; NUFFIELD COUNCIL ON BIOETHICS, NOVEL TECHNIQUES FOR THE
PREVENTION OF MITOCHONDRIAL DNA DISORDERS: AN ETHICAL REVIEW (2012). On the role of the egg donor,
see Erica Haimes & Ken Taylor, Rendered Invisible? The Absent Presence of Egg Providers in U.K. Debates on the
Acceptability of Research andTherapy for Mitochondrial Disease, 33 MONASH BIOETHICS REV. 360–378 (2015).
On the value of MRTs, see Tina Rulli,What Is the Value of Three-Parent IVF?, 46 HASTINGS CENT. REP. 38-47
(2016).
18 See Sarah Chan & Maria de Jesu´s Medina-Arellano, Genome Editing and International Regulatory Challenges:
Lessons From Mexico, 2 ETHICS MED. & PUB. HEALTH 426–434 (2016); I. Glenn Cohen, Julian Savulescu
& Eli Y. Adashi, Transatlantic Lessons in Regulation of Mitochondrial Replacement Therapy, 348 SCIENCE 178–
180 (2015); Tetsuya Ishii, Potential Impact of Human Mitochondrial Replacement on Global Policy Regarding
Germline Gene Modification, 29 REPROD. BIOMED. ONLINE 150–155 (2014); Guido Pennings, International
Harmonization andMitochondrial Replacement, 29 REPROD. BIOMED. ONLINE 269 (2014); Johanna Schandera
&TimK.Mackey,Mitochondrial Replacement Techniques: Divergence in Global Policy, 32 TRENDSGENET. 385–
390 (2016).
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Although both authors find that carrying out MRTs is, in principle, ethically
permissible—one of the authors has written on the ethical permissibility of MRTs and
theother on the importanceof embryo and stemcell research for unmethealthneeds—
the focus of this paper is onMRTs andMexico’s rule of law.
MITOCHONDRIA19
All eukaryotic organisms, humans included, possess a double membrane-bound or-
ganelle called mitochondria, which resides in the cytoplasm. This organelle, among
other things, produces the energy cells need to work properly. Two important char-
acteristics of mitochondria are that they are solelymaternally inherited20 and that they
possess their own DNA, which, again, is located outside the cell’s nucleus. Whereas
nuclear DNA accounts for 99.9 per cent of total human DNA, mitochondrial DNA
(henceforth mtDNA), with its 37 genes, accounts for the other 0.1 per cent.21
Given thatmitochondria are responsible for generating the energy cells need towork
properly, it is not surprising that when they do not work as they should there may be
adverse effects on human health, ranging frommild to devastating in their severity.Mi-
tochondrial diseases are caused by the inadequate function ofmitochondria.These dis-
eases can occur because of problems within the mtDNA, itself, or because of the effect
of the nuclear DNA on mitochondrial function.22 In this paper, we will only focus on
problems related to the function of mtDNA, itself.
Roughly speaking, mitochondrial DNA diseases (henceforth mtDNA diseases) oc-
cur when enough mitochondria with deleterious DNA mutations exist for the produc-
tion of energy to be insufficient for cells to work properly. Let’s remember that each
cell has many mitochondria. Deleterious mutations can (a) occur spontaneously dur-
ingmtDNA replication, (b) be inherited, or (c) both.Thesemutations can occur across
all mitochondrial genomes—a condition referred to as ‘homoplasmy’; or they can only
occur in some mitochondrial genomes—a condition referred to as ‘heteroplasmy’.
Women with homoplasmic deleterious mutations will always pass this condition to
their children, and thosewithheteroplasmic deleteriousmutationswill pass amixof un-
healthy and healthymitochondria to their children.The severity of themtDNAdisease
and whether it will manifest at all, in children of heteroplasmic women, depends on the
type of mtDNAmutation and the load of deleteriously mutated mitochondria. Predic-
tion on this outcome is difficult, since mitochondria are not inherited in a Mendelian
19 This section draws from Ce´sar Palacios-Gonza´lez, Ethics of Mitochondrial Replacement Techniques: A Haber-
masian Perspective, 31 BIOETHICS 27–36 (2017).
20 This could change if functional oocytes were to be generated from male cells. HENRY T. GREELY, THE END OF
SEX AND THE FUTURE OF HUMAN REPRODUCTION (1st ed., 2016); Ce´sar Palacios-Gonza´lez, John Harris &
Giuseppe Testa,Multiplex Parenting: IVG and the Generations to Come, 40 J. MED. ETHICS 752–758 (2014).
21 Stephen Anderson et al., Sequence and Organization of the Human Mitochondrial Genome, 290 NATURE 457–
465 (1981); Robert W. Taylor et al.,The Determination of Complete Human Mitochondrial DNA Sequences in
Single Cells: Implications for the Study of Somatic Mitochondrial DNA Point Mutations, 29 NUCLEIC ACIDS RES.
e74–e74 (2001).
22 NUFFIELD COUNCIL ON BIOETHICS, supra note 17, at vii.
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manner; rather, their inheritance depends on a phenomenon called the ‘mitochondrial
DNA genetic bottleneck23’.
It must be clear that, up to this point, we have discussed mtDNA diseases, in plu-
ral, because such diseases cannot be categorized in a singular fashion. Deleterious mu-
tations in mtDNA can cause Leigh’s syndrome, deafness, blindness, stroke, dementia,
major organ failure, heart failure, andLeber’s hereditary optic neuropathy, amongother
conditions.24 TheUKDepartment of Health asserts that 1 in every 6500 children born
in the UK has an mtDNA disease.25
As there is presently no cure for mtDNA diseases, women who have them (and are
aware that they have them) andwant to have genetically related kin face a difficult repro-
ductive choice. Homoplasmic women know that if they reproduce naturally, all of their
children will inherit their homoplasmic condition and will probably end up with a clin-
ical manifestation of the disease. Heteroplasmic women, on the other hand, know that
it is probable that their children will possess a deleterious mutant load that could cause
the disease to manifest. Until now, women with mtDNA diseases who want to have
genetically related children have had to choose between natural procreation or, where
available, preimplantation genetic diagnosis (PGD)—with the latter option only avail-
able to heteroplasmic women.
The idea behind using PGD is that physicians are able to select an embryo that pos-
sesses nomutant load, or one that possesses amutant load so small that the clinicalman-
ifestationof the diseasewill not occur.26 Aproblemwith this approach is that it does not
work for homoplasmic women, as implied above, and that, in the case of heteroplasmic
women, it only works when there is enough data on the specificmtDNAmutation.This
suggests that PGD is not useful formutations that are uncommon or private. It must be
obvious that there are other reproductive options for women affected by mtDNA dis-
eases: egg and embryo donation. However, these forgo thematernal genetic link that is
of paramount importance to some.
Another option (which was merely theoretical until recently) is for women to opt
for one of two recently developed techniques that would allow them, if successful, to
have children free from their mtDNA disease. These techniques are maternal spin-
dle transfer and pronuclear transfer, and these have been jointly called ‘mitochondrial
23 ‘During the production of primary oocytes, a selected number of mitochondrial DNA (mtDNA) molecules
are transferred into each oocyte. Oocyte maturation is associated with the rapid replication of this mtDNA
population.This restriction-amplification event can lead to a random shift ofmtDNAmutational load between
generations and is responsible for the variable levels of mutated mtDNA observed in affected offspring from
mothers with pathogenic mtDNA mutations’ Robert W. Taylor & Doug M. Turnbull, Mitochondrial DNA
Mutations in Human Disease, 6 NAT. REV. GENET. 389–402, 393 (2005).
24 UK DEPARTMENT OF HEALTH, MITOCHONDRIAL DONATION: A CONSULTATION ON DRAFT REGULA-
TIONS TO PERMIT THE USE OF NEW TREATMENT TECHNIQUES TO PREVENT THE TRANSMISSION OF A
SERIOUS MITOCHONDRIAL DISEASE FROM MOTHER TO CHILD (2014), https://www.gov.uk/government/
uploads/system/uploads/attachment data/file/285251/mitochondrial donation consultation document
24 02 14 Accessible V0.4.pdf (accessed Sept. 14, 2015).
25 AndrewM. Schaefer et al., Prevalence ofMitochondrial DNADisease in Adults, 63 ANN.NEUROL. 35–39 (2008).
26 Hubert J.M. Smeets et al., Preventing the Transmission ofMitochondrial DNADisorders Using Prenatal or Preim-
plantation Genetic Diagnosis, 1350 ANN. NY ACAD. SCI. 29–36 (2015).
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replacement techniques’.27 It is important to highlight that these techniques only tackle
mtDNA diseases.28
In PNT, assisted reproductive techniques (ARTs) are employed to create two zy-
gotes. One is created with the intending parents’ gametes (or the intending mother’s
egg and a donor’s sperm).The second is createdwith an egg that has beendonated from
a woman29 without an mtDNA disease, and the intending father’s (or donor’s) sperm.
After fertilization occurs, the nuclear material of the egg and sperm are enclosed in dif-
ferent membranes, called the male and female pronuclei.These pronuclei are removed
from both zygotes during the first 24 hours and prior to their fusion.The pronuclei that
include the donor’s nuclear material and the enucleated cell that was originally pro-
ducedwith the intendingmother’s oocyte are discarded.The intending parents’ pronu-
clei are then transferred to the enucleated zygote that was produced with the donor’s
egg. At this point, the intending parents’ nuclear material is housed in a cell possessing
healthy mitochondria and is transferred into the intending mother or a surrogate.30
In MST, oocytes are obtained from the intending mother and a healthy donor
through ARTs. The chromosomes of both oocytes, which at the moment of cellular
division (metaphase II) are found to one side of the oocyte in a spindle shape group,
are removed.Thedonor’s chromosomes and the intendingmother’s enucleated oocyte
are discarded. Afterwards, the intending mother’s chromosomes are transferred to the
donor’s enucleated oocyte. The reconstructed egg, with healthy mitochondria, is then
fertilized in vitro and transferred to the intending mother or a surrogate.31
Children born after PNTorMSTwill not have anmtDNAdisease if during the pro-
cedures there was not enough carryover of deleteriously mutatedmitochondria for the
disease to clinically manifest.32 In this case, the donor’s healthy mitochondria will be
passed to future generations when women born after MST or PNT reproduce using
their own eggs.
27 For a discussion on the appropriateness of this terminology, see Vardit Ravitsky, Stanislav Birko & Raphaelle
Dupras-Leduc,The ‘Three-Parent Baby’: A Case Study of How Language Frames the Ethical Debate Regarding an
Emerging Technology, 15 AM. J. BIOETHICS 57–60 (2015); Palacios-Gonza´lez (2016), supra note 17; Ainsley
J. Newson & Anthony Wrigley, Is Mitochondrial Donation Germ-Line Gene Therapy? Classifications and Ethi-
cal Implications, 31 BIOETHICS 55–67 (2017); Franc¸oise Baylis, Human Nuclear Genome Transfer (So-Called
Mitochondrial Replacement): Clearing the Underbrush, 31 BIOETHICS 7–19 (2017).
28 Lyndsey Craven et al., Pronuclear Transfer in Human Embryos to Prevent Transmission of Mitochondrial DNA
Disease, 465 NATURE 82–85 (2010); Masahito Tachibana et al., Mitochondrial Gene Replacement in Primate
Offspring and Embryonic Stem Cells, 461 NATURE 367–372 (2009); Akiko Yabuuchi et al., Prevention of Mi-
tochondrial Disease Inheritance by Assisted Reproductive Technologies: Prospects and Challenges, 1820 BIOCHIM.
BIOPHYS. ACTA 637–642 (2012).
29 In this paper, wewill not address the philosophical question if the egg donor is, or not, a second geneticmother.
30 Craven et al., supra note 28; Louise A. Hyslop et al., Towards Clinical Application of Pronuclear Transfer to
Prevent Mitochondrial DNA Disease, 534 NATURE 383–386 (2016); NUFFIELD COUNCIL ON BIOETHICS, supra
note 17.
31 NUFFIELD COUNCIL ON BIOETHICS, supra note 17; Tachibana et al., supra note 28.
32 Hyslop et al., supra note 30; Mitsutoshi Yamada et al., Genetic Drift Can Compromise Mitochondrial Replace-
ment by Nuclear Transfer in Human Oocytes, 18 CELL STEM CELL 749–754 (2016); Eunju Kang et al., Mito-
chondrial Replacement in Human Oocytes Carrying Pathogenic Mitochondrial DNAMutations, NATURE (2016),
http://www.nature.com/nature/journal/vaop/ncurrent/full/nature20592.html (accessed Dec. 7, 2016).
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TWO RELEVANT CHARACTERISTICS
Two characteristics of MRTs are relevant in terms of law and regulation. The first is
that both PNT andMST can be instances of either germline or somatic modifications.
As stated above, PNT and MST affect the germline, in the sense that they are mod-
ifications that will be inherited by future generations if a female individual produced
through them reproduces. However, both techniques are somatic modifications when
a male embryo is selected for, in the sense that the modifications will not be inherited
by future generations if the individual produced through them reproduces.
It is possible toboth select the sexof the embryo thatwill be created and select the sex
of the embryo that will be transferred to the mother or a surrogate.Through PGD one
can choose the sex of the embryo that will be transferred.This means that if post-MST
a female embryo and a male embryo are produced and we want to avoid modifications
being passed down, we can identify themale embryo and transfer it. On the other hand,
through sperm sorting we can choose a sperm with an ‘X’ or a ‘Y’ sex chromosome and
thus select the sex of the embryo that will be created.This technique works prefertiliza-
tion and also allows us, for example, to create only male embryos.
The second characteristic that is relevant for law and regulation is the difference be-
tween PNT andMST in terms of the time at which they occur.WhereasMST involves
oocytes, PNT involves zygotes. InMST, the donor’s oocyte is destroyed for the sake of
the intending mother’s oocyte. In PNT, however, an early embryo is destroyed for the
sake of another early embryo. Inmoral terms, this difference is of paramount relevance
for those who hold that human embryos possess the same moral status as human per-
sons. This difference between PNT and MST is also important because, as we will see
below, certain jurisdictions protect ‘human life’ from the moment of fertilization.
MEXICO
The United Mexican States, commonly known as Mexico, is a federal republic of 32
states.33 The states’ powers, at both the local and the federal level, are divided into
executive, legislative, and judicial powers. At the federal level, the executive power
falls to the President; the legislative power falls to the Congress of the Union (hence-
forth Congress), which is divided into two chambers: the Senate and the Chamber of
Deputies; and the judicial power falls to the Supreme Court of Justice (henceforth the
Supreme Court).
Mexico’s highest law is the Federal Constitution and in it (Articles 39 to 41) the
form of government and the integration of the Federal Republic is established. Each
of the 32 states has a local constitution, but the Federal Constitution overrides lower
sources of law at all times—and, from 2011, also international conventions related to
human rights protections—and local constitutions must be aligned with the Federal
Constitution’s provisions.
The Supreme Court exercises constitutional control and plays an important role in
interpreting the Federal Constitution.34 It has the power to strike down any local law
that contradicts or contests the Federal Constitution, and it can also pronounce itself
33 Until last year the political composition of the country was 31 states plus a federal district. The federal district
is now the State of Mexico City.
34 For an account of the Supreme Court’s recent history, see Alejandro Madrazo & Estefan´ıa Vela,TheMexican
Supreme Court’s (Sexual) Revolution?, 89 TEX. L. REV. 1863–1893 (2011).
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in favor of the constitutionality of any challenged law. There are two ways to create
jurisprudence, which is analogous to precedent/case law in common law systems.35 The
first is stipulated by the reiteration criteria. According to this criteria, rulings made by
the Supreme Court and all federal judges and magistrates—which are called relevant
resolutions—create jurisprudencewhenfive relevant resolutions are ruledusing the same
lineof legal reasoning.Thesecondway to create jurisprudence iswheneight of the eleven
members of the Supreme Court agree on the main point of a particular relevant case.
Jurisprudence of the Supreme Court is binding to all lower courts due to its hierarchy
within the judicial system.
MEXICO’S RULE OF LAW AND ASSISTED REPRODUCTION
The Federal Constitution neither defines a human embryo nor expressly defends hu-
man life from the moment of conception or fertilization. Despite this, conservatives
have tried to argue that human life is protected from its beginning under Article 1 of
the Federal Constitution36:
(. . . ) Any discrimination based on ethnic or national origin, gender, age, disabilities, so-
cial status, health condition (. . . ) or any other reason which attempts against human dig-
nity and which is directed to either cancel or undermine people’s rights and liberties is
prohibited.37
According to conservatives, abortion and the destruction of human embryos are an af-
front to the right to life and the human dignity of those destroyed or terminated.Thus,
these practices are legally prohibited. Although the Supreme Court recently favored
this interpretation38 in a ruling regarding abortion due to severe congenital conditions,
it established in its latest ruling (also regarding abortion) that:
It is clear that from a plain reading of theMexican Constitution, we did not explicitly find
in anyof its text the institutionof a specific right to life, the value of life, or other expression
that allows todetermine that life has a specificnormative protection through aprohibition
or mandate directed at the state’s authorities.39
Diverging from previous rulings on abortion, where the focus was on civil law which
protects the interests and rights of the unborn, in its latest ruling the SupremeCourt fa-
voredwomen’s reproductive rights over the life of the unborn and focusedon the extent
35 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, LEY DE AMPARO, REGLAMENTARIA DE LOS
ART´ICULOS 103 Y 107 DE LA CONSTITUCIO´N POL´ITICA DE LOS ESTADOS UNIDOS MEXICANOS Title four (2016),
http://www.diputados.gob.mx/LeyesBiblio/pdf/LAmp 170616.pdf (accessed Oct. 14, 2016).
36 All translations here are our own unless otherwise indicated.
37 CONGRESOCONSTITUYENTE, CONSTITUCIO´NPOL´ITICADE LOSESTADOSUNIDOSMEXICANOS (1917 as amended
to Jan. 27, 2016), http://www.diputados.gob.mx/LeyesBiblio/htm/1.htm (accessed Oct. 14, 2016).
38 SUPREMA CORTE DE JUSTICIA DE LA NACIO´N, TESIS JURISPRUDENCIAL NUM. P./J. 14/2002 DE SUPREMA
CORTE DE JUSTICIA, PLENO (ACCIONES DE INCONSTITUCIONALIDAD) (2002), http://suprema-corte.vlex.
com.mx/vid/jurisprudencial-pleno-jurisprudencia-27193739 (accessed Oct. 14, 2016).
39 SUPREMA CORTE DE JUSTICIA DE LA NACIO´N, ACCIO´N DE INCONSTITUCIONALIDAD 146/2007 Y SU ACUMULADA
147/2007 153 (2008), https://www.unifr.ch/ddp1/derechopenal/temas/t 20090316 03.pdf (accessedOct.
14, 2016).
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of protection of the constitutional right to life.40 In practical terms, this ruling means
that there is no recognized right to life from the moment of conception or fertilization
at the federal level, and thus local abortion laws that allow for on-demand abortion up to
the 12thweek (such as those of the State ofMexicoCity) do not contradict the Federal
Constitution.41
Additionally, this ruling found that articles protecting human life that are in, or can
be derived from, international declarations, covenants, and treaties of which Mexico
is signatory do not expressly establish when life begins or the moment from which it
should be protected. An exception to this finding is provided in Article 4 of the Amer-
ican Convention on Human Rights, of which Mexico is signatory. This article asserts
that: ‘Every person has the right to have his life respected.This right shall be protected
by law and, in general, from the moment of conception. No one shall be arbitrarily de-
prived of his life’.42 Although this article asserts that human life should, in general, be
protected from the moment of conception, Mexico is not obliged to recognize this be-
cause theMexican government made an interpretative declaration of that specific arti-
cle at themoment of ratification.They considered thedecision toprotect life ‘in general’
from the moment of conception as one that should be taken by each individual state.
In relation to paragraph 1 of Article 4, [the Mexican government] considers that the ex-
pression ‘in general’ used in such paragraph does not constitute an obligation to adopt or
maintain in force legislation that protects life ‘from themoment of conception’ since such
matters belong to the reserved dominion of the States43
At the federal level, the General Health Law44 (a secondary piece of legislation) pro-
vides the legal definition of an embryo. Before commenting on this definition we will
briefly elaborate on this law. The General Health Law regulates the right to the pro-
tection of health afforded to every person according to Article 4 of the Federal Consti-
tution. In addition to the General Health Law, each state has its own health law. But,
as described above, when there is conflict between a local health law and the General
Health Law, the latter overrules the former.
It is reasonable to suppose that a legal definition of an embryo would appear
in the section of the law dedicated to assisted reproduction. However, the General
Health Law does not specifically regulate assisted reproduction.45 For at least 10 years,
40 Maria de Jesu´sMedina-Arellano,StemCell Regulation inMexico:CurrentDebates andFutureChallenges, 5 STUD.
ETHICS L. & TECH. 1–33, 17 (2011).
41 For a comment on this sentence, seeMaria de Jesu´s Medina-Arellano,TheNeed for Balancing the Reproductive
Rights of Women and the Unborn in the Mexican Courtroom, 18MED. L. REV 427–433 (2010).
42 ORGANIZATION OF AMERICAN STATES, AMERICAN CONVENTION ON HUMAN RIGHTS ‘PACT OF SAN JOSE,
COSTA RICA’ (1978), http://www.oas.org/dil/treaties B-32 American Convention on Human Rights.htm
(accessed Oct. 14, 2016). See note 16, for an account of the differences between ‘conception’ and ‘fertiliza-
tion’ in Mexican Law.
43 SUPREMA CORTE DE JUSTICIA DE LA NACIO´N, supra note 39, at 173.
44 That for all intends and purposes is a national health law.
45 At present time, there are various assisted reproduction amendments to the General Health Law that
are being discussed. Sara Reardon, Mexico Proposal to Ban Human-Embryo Research Would Stifle Sci-
ence, 540 NAT. NEWS 180 (2016); CE´SAR PALACIOS-GONZA´LEZ, UNA PROPUESTA DE LEY QUE PROHI´BE
EMBARAZOS Y TRASPLANTES ANIMAL POL´ITICO (2016), http://www.animalpolitico.com/blogueros-
una-vida-examinada-reflexiones-bioeticas/2016/12/14/una-propuesta-ley-prohibe-embarazos-trasplantes/
(accessed Dec. 15, 2016).
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amendments to this law have been discussed inCongress, but, thus far, none have been
successfully made into law. This important legal lacuna is recognized by academics,
stakeholders, and politicians from all political parties, who have repeatedly called for
legislation to be passed on this important subject. Although there are no specific as-
sisted reproduction laws, the General Health Law does provide a definition of what
should be understood, for legal purposes, as an embryo in the title: ‘Donation, Trans-
plants and Loss of Life’. In Article 314, section VIII of this title, an embryo is defined as
‘the product of conception from the moment of it, and until the end of the twelfth ges-
tational week’.46 Related to this, Article 330 section II states that the use of embryonic
or foetal tissues that are the product of induced abortions is forbidden, regardless of the
goal of such use. At this point, it should be clear that, in relation to Article 330, MRTs do
not break the law, since they do not require tissues of this kind.
A consequence of the lack of specific regulation concerning assisted reproduction
is that, at the federal level, no organization or authority regulates, evaluates, and com-
piles information about the way in which ARTs are carried out in Mexico, or the per-
sons who carry them out.47,48 It also means, among other things, that there is no legal
certainty about what kind of information should be collected for epidemiological and
legal purposes, and the length of time that gametes and embryos should be stored. In
terms of actual clinical practice, the Mexican Association of Reproductive Medicine
and the Latin American Network of Assisted Reproduction (RedLara)—among other
professional bodies—provide recommendations and regulations relating to the prac-
tice of assisted reproduction in Mexico. Nonetheless, clinics that offer assisted repro-
ductive services follow their recommendations and regulations only on a voluntary
basis.
At this point, it could be thought that, in terms of the General Health Law, there
are no restrictions on MRTs in Mexico. But surprisingly, the Regulations of the Gen-
eral Health Law on Health Research include some directives that apply to MRTs.
This regulatory document is an independent body of text (in the sense that it is not
contained within the General Health Law) and, as its names suggests, further regu-
lates certain aspects of the General Health Law. Article 56 of this regulation asserts
that:
Research on assisted fertilization will only be admissible when it is applied to solve sterility
problems that cannot be solved otherwise [emphasis added], respecting the couple’s moral,
cultural, and social point of view, even if these differ from those of the researcher.49
46 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, LEY GENERAL DE SALUD (1984 as amended to Jan. 1,
2016), http://www.diputados.gob.mx/LeyesBiblio/pdf/142 010616.pdf (accessed Dec. 15, 2016).
47 At the state level, certain states have surrogacy laws but these laws do not refer to assisted reproduction per se,
but to the rights and obligations of each party when entering into a surrogacy agreement.
48 It must be said that the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) estab-
lishes regulations for clinics offering assisted reproduction, but only in terms of facilities.
49 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, REGLAMENTO DE LA LEY GENERAL DE
SALUD EN MATERIA DE INVESTIGACIO´N PARA LA SALUD (1987), http://www.diputados.gob.mx/LeyesBiblio/
regley/Reg LGS MIS.pdf (accessed Dec. 15, 2016).
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The text defines ‘assisted fertilization’ in a way that covers fertility practices carried out
in vitro, includingMRTs.50 Thus, if research onMRTs is used to solve sterility51 prob-
lems that cannot be otherwise solved, then it would not violate Article 56; if research
onMRTs is not used to solve sterility problems that cannot be otherwise solved, then it
would violate Article 56. It should be clear that, at this point in time, all applications of
MRTs are experimental in nature52, and according toArticle 3 section III of theRegula-
tions of theGeneral Health Law onHealth Research they should be regarded as part of
health research, since they entail actions that contribute to the prevention and control
of health problems.53
Now, if a woman’s eggs have mitochondria with deleterious DNA mutations such
that the embryos producedwith themwill never be able to implant (making pregnancy
impossible), then research onMRTs to solve this problem does not violate Article 56.
This is becauseMRTs solve a sterility problem that cannot be otherwise solved. On the
other hand, research on MRTs (ie research on assisted fertilization) for helping fertile
women to have children without a mtDNA disease would violate Article 56. This is so
because research on MRTs is not intended to solve sterility problems that cannot be
solved otherwise.
At this point, we can conclude that—assuming this interpretation of the law is correct
and with the information we possess about the case—Zhang’s team violated Article 56 of
this regulation.54 They did so because their research on MST included a woman who
could get pregnant and deliver a live baby. In other words, research on MST was not
used to solve a sterility problem that could not be otherwise solved. The Regulations of
the General Health Law onHealth Research do not establish a specific sanction for the
violation of this article; however, they do assert that sanctions for violations of these
regulations will be established by ‘the law’, in this case the General Health Law.
Article 416 of the General Health Law asserts that violations to this law and its reg-
ulations (eg Regulations of the General Health Law on Health Research) will incur
administrative sanctions.55 In Article 417, these sanctions are outlined: (a) a warning
with a subpoena, (b) a fine, (c) a temporal or definitive shutdown that can be partial
50 Article 40 section XI defines assisted fertilization as follows: ‘That in which the insemination is artificial (ho-
mologous or heterologous) and includes in vitro fertilization’. Id. Now, in vitro fertilization is not defined in
this law. However, it is reasonable to contend that reproductive practices that inherently include in vitro fertil-
ization fall under the umbrella of assisted fertilization.
51 Sterility is defined, elsewhere, as the failure to achieve a clinical pregnancy after 12 months
of regular unprotected sexual intercourse. INSTITUTO MEXICANO DEL SEGURO SOCIAL, DI-
AGNO´STICO DE LA PAREJA INFE´RTIL Y TRATAMIENTO CON TE´CNICAS DE BAJA COMPLEJIDAD (2012),
http://www.imss.gob.mx/sites/all/statics/guiasclinicas/621GRR.pdf (accessed Dec. 15, 2016).
52 If carrying out MRTs were common clinical practice, then Article 56 would not engage, as it is the case with
the current practice of PGD, for example.
53 Article 3: ‘Health research entails carrying out actions that contribute: (. . . ) III. To the prevention and control
of health problems’ CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, supra note 49.
54 Someone could claim that Zhang’s team’s actions were a research step toward solving sterility problems that
cannot be solved otherwise, and thus legal. Even when this might seem compelling, we contend that there is a
strong reason todoubt thatZhang’s team’s treatmentof the Jordanian couplewasonly a step in research toward
solving mtDNA diseases that cause sterility problems that cannot be solved otherwise. This is that when the
team was, repeatedly, asked about Mexican regulations they never made this important precision, even when
a big part of the whole controversy has revolved aroundMRTs regulations.
55 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, supra note 46.
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or total, and (d) incarceration for up to 36 hours.56 The health authorities determine
which of the above apply in each specific case. If the authorities decide on a fine, then
its amount is established in conformity with Article 422, and can go up to 16,000 times
the minimumwage (which roughly equates to 61,953.64 US dollars).57
Furthermore, another sanction of the General Health Law could apply to the vio-
lation of Article 56, depending on the fact if research on MRTs can be classified as re-
search on human beings. It is true that carrying outMSTdoes not equate to carrying out
research on a human being; however, when we consider MST in conjunction with the
woman who will be pregnant we realize that this research possesses a central human
element, and thus could be constructed as research on a human being. Article 101 of
theGeneralHealth Lawdictates that persons carrying out research on human beings in
contravention of this law or other applicable provisions (eg Regulations of the General
Health Law on Health Research) are worthy of sanctions.58
Now, if research on MRTs is considered research on human beings, then in this
particular case a violation of Article 56 of the Regulations of the General Health
Law on Health Research would engage Article 101 of the General Health Law.
The sanctions for a violation of Article 101 of the General Health Law are found
in Article 421, which states that those who violate Article 101 will receive a fine
between 6000 and 12,000 times the minimum wage (which roughly equates to a
fine between 23,271.83 and 46,543.66 US dollars).59 These sanctions are meant to
be applied by the Federal Commission for the Protection Against Sanitary Risks
(COFEPRIS).60
In conclusion, under our interpretation of the law and with the available information
about the case, we can assert that Zhang’s team broke the Regulations of the Gen-
eral Health Law on Health Research, and that it is very probable that they also broke
regulations regarding research on human beings. This conclusion, obviously, stands
in stark contrast to Zhang’s team’s statements about the legality of their research in
Mexico.
MEXICO AND THE RIGHT TO LIFE
Another way in which we can elucidate the instances in which MRTs and certain ap-
plications ofMRTs are legally prohibited inMexico, in addition to the specifications in
Article 56, is to shift our attention from federal laws and regulations to state laws and
regulations.Doing so allows us to identify stateswith laws that protect life from themo-
ment of fertilization. We can then determine which states legally permit PNT, because
PNT involves the intentional destruction of a single cell human embryo and this would
be prohibited under such laws.61 At this point, let’s remember two things: Mexico’s
Federal Constitution does not protect life from the point of conception or fertilization
and laws protecting human life from the point of conception would not apply to PNT
56 Id.
57 Currency exchange rate calculated at 1 US dollar to 18.83Mexican pesos (Oct. 10, 2016).
58 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, supra note 46.
59 Id.
60 Mar´ıa de Jesu´sMedina-Arellano,TheRise of StemCellTherapies inMexico: Inadequate Regulation orUnsuccessful
Oversight?, 2 REVISTA REDBIOE´TICA/UNESCO 63–78 (2012).
61 In these states, the destruction of surplus embryos after bothMRTs would also be legally prohibited.
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Figure 1.  State where MST was carried out. Purple, states where human life is
protected from the moment of conception (ie implantation). Green, states where PNT is
prohibited because human life is protected from the moment of fertilization. Orange,
state where PNT is prohibited if the would-be-enucleated embryo is first created for a
non-reproductive purpose.
(given that conception is understood as themoment at which implantation occurs, and
the destruction of human embryos for PNT occurs prior to implantation). In Mex-
ico, 18 local constitutions protect life from the point of conception or fertilization (see
Fig. 1).
Interestingly, Jalisco is one of the states that constitutionally protects life from the
moment of fertilization. In this way, it clearly diverts from the Federal Constitution:
Article 4. (. . . ) Likewise, the State of Jalisco recognizes, protects and underwrites the right
to life of every human being, by expressively maintaining that from the moment of fertil-
ization he is under the protection of the law and that he is reputed as born for all legal
effects, until his natural death.62
Let’s remember that Zhang’s team carried out MST in the city of Guadalajara, which
is within the state of Jalisco. This means two things. First, if Zhang’s team had carried
out PNT (which they did not), then they would have broken this law. Secondly, if after
MST they destroyed the other three aneuploid embryos, while in Jalisco, then these
actionswould have clearly violatedArticle 4 of the state’s constitution. At this point, we
do not know the embryos’ fate.We do not know if they were destroyed, cryopreserved,
or taken to another jurisdiction.
62 CONGRESO CONSTITUYENTE DEL ESTADO LIBRE Y SOBERANO DE JALISCO, CONSTITUCIO´N POL´ITICA DEL
ESTADO DE JALISCO (1917 as amended to Apr. 10, 2014), http://www.jalisco.gob.mx/sites/default/files/
constituci n politica del estado de jalisco.pdf (accessed Dec. 15, 2016).
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If Zhang’s teamwere to declare that they intentionally destroyed the aneuploid em-
bryos while in Guadalajara, or Jalisco, then we might question whether the state could
try to prosecute them. Given that there is no precedent for this type of case (ie cases
relating toMRTs), wemust look to other cases in which persons have been prosecuted
by the state for intentionally destroying embryos: abortion cases. Jalisco is among the
most conservative states in Mexico and in addition to having laws that protect human
life from themoment of fertilization it has a very punitive penal code in regard to abor-
tion. Among Mexican states, Jalisco has one of the highest percentages of prosecution
against women who abort, or who are suspected of having had an abortion.
Thirty-two women were prosecuted from 2007 to 2012 under such charges, and,
of these, 25 were convicted.63 Despite this, a person who intentionally destroys a hu-
man embryo in vitro while carrying out ARTs, or as part of ART research (eg MRTs),
cannot be prosecuted under abortion laws. This is because Jalisco’s penal code, Ar-
ticle 227, defines abortion as ‘the death of the product of conception at any time
during pregnancy’.64 It should be obvious that without a pregnancy there can be no
abortion.
Another option for the state would be to prosecute the intentional destruction of
embryos as a homicide.65 The state could follow this path because Article 213 of the
state’s penal code asserts that: ‘From twelve to eighteen years in prison will be im-
posed to the person that takes the life of another one’.66 And section I of Article 214
asserts that an injury will be considered fatal and thus sanctions of Article 213 will en-
gage when: ‘the death is due to the alterations caused by the injury to the interested
organ or organs, or that death is due as immediate or determinate consequence of the
injury’.67 These articles could apply to cases of embryo destruction during PNTor after
MST because, in Jalisco, a single cell embryo is, for all legal purposes, reputed as born
from the moment of fertilization. Even if the embryos would die naturally if they were
to be transferred to awoman, their intentional destruction could still be prosecuted since,
in legal terms, their destruction would be akin to intentionally killing someone with a
condition that will kill her in a couple of hours.
In conclusion, in Mexico, nine states prohibit PNT through laws protecting human
life from themoment of fertilization. In Jalisco, specifically, the intentional destruction
of human embryos could be prosecuted under criminal charges as homicide.
MEXICO AND GENOME MODIFICATION AND GENETIC ENGINEERING
In Mexico, no federal law specifically concerns human genetic engineering or hu-
man genome modification. The General Health Law has a section on The Human
63 XIMENA ANDIO´N & REBECA RAMOS, OMISIO´N E INDIFERENCIA. DERECHOS REPRODUCTIVOS EN ME´XICO 32
(2013), http://informe.gire.org.mx/caps/cap1.pdf (accessed Oct. 20, 2016).
64 CONGRESO DEL ESTADO DE JALISCO, CO´DIGO PENAL PARA EL ESTADO LIBRE Y SOBER-
ANO DE JALISCO (1982 as amended to Apr. 9, 2013), http://www.jalisco.gob.mx/sites/default/
files/C%25C3%25B3digo%2520Penal%2520para%2520el%2520Estado%2520Libre%2520y%2520
Soberano%2520de%2520Jalisco%2520%252826OCTU12%2529.pdf (accessed Oct. 15, 2016).
65 InMexico, the concept ‘homicide’ is used todenote towhat in theUSA is referred to as ‘manslaughter’, whereas
‘typified homicide’ is used to refer to what in the USA is referred as ‘homicide’.
66 CONGRESO DEL ESTADO DE JALISCO, supra note 64.
67 Id.
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Genome68, but it simply addresses the gathering and use of human genetic informa-
tion. As a matter of fact, this section of the General Health Law does not engage with
human genome modification or human genetic engineering of any kind.69
The only piece of federal legislation that directly addresses genetic engineering and
genome modification is the 2005 Law on the Biosafety of Genetically Modified Or-
ganisms (GMOs). This piece of federal legislation was created with the intention of
managing actual and possible risks related to the use and development of GMOs, in
addition to promoting the development of this scientific area. Although this law reg-
ulates GMOs—and thus it is reasonable for us to expect to find in it regulations re-
garding human genetic engineering and human genomemodification—it explicitly ex-
cludes humans from its oversight by means of its definition of GMOs. In Article 3,
section XXI it asserts:
Genetically modified organism: Any living organism, with the exception of human beings
[emphasis added], that has acquired a novel genetic combination, generated through the
specific use of techniques of modern biotechnology (. . . )70
Thus, at the federal level, there is no law prohibiting human genetic engineering or
genome modification at either the somatic or the germline level. Therefore, MRTs are
not prohibited under this law. Although there is no federal law covering this ground,
Mexico is signatory to international declarations that address the modification of the
human germline. For example, Mexico is signatory of the Universal Declaration on
the Human Genome and Human Rights, which explicitly addresses human germline
modifications:
Article 24. (. . . ) [The International Bioethics Committee of UNESCO] shouldmake rec-
ommendations, in accordance with UNESCO’s statutory procedures, addressed to the
General Conference and give advice concerning the follow-up of this Declaration, in par-
ticular regarding the identification of practices that could be contrary to human dignity,
such as germ-line interventions.
Although this article states that germline interventions could be contrary to humandig-
nity, the conditional form of this claim, ‘could be’, is of paramount importance. This
means that in terms of the international covenants, treaties, and declarations thatMex-
ico has signed and ratified, there is no explicit prohibition against PNT or MST that
Mexico must follow.
At the state level the State of Mexico City (previously the Federal District) is the
only state with laws regarding human genetic manipulation. Its penal code has an entire
chapter (Chapter II) on genetic manipulation and the criminal sanctions that will be
imposed on those who break such laws. Despite this, it is quite a short chapter, with
only two articles. It is also interesting to note that the nature of the sanctions is criminal,
68 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, supra note 46 at Chapter Five Bis.
69 Chan &Medina-Arellano, supra note 18.
70 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, LEY DE BIOSEGURIDAD DE ORGANISMOS
GENE´TICAMENTE MODIFICADOS (2005), http://www.diputados.gob.mx/LeyesBiblio/pdf/LBOGM.pdf (ac-
cessed Oct. 15, 2016).
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whereas the General Health Lawmainly imposes administrative sanctions. Article 154
of this penal code establishes that:
Between two and six years in prison, disqualification, suspension for the same amount
of time from working in posts, jobs or public commissions, profession or trade, will be
imposed to those who:
I. with different goals to the elimination or diminishment of grave diseases ormaladies,
manipulates human genes such that the genotype is altered;
II. fertilize human oocytes for any goal different to human procreation; and
III. create human beings by means of cloning or carry genetic engineering procedures
for illicit ends.71
It is clear that carrying outMRTs in the State ofMexicoCity in order to help women or
couples have children without an mtDNA disease does not violate section I of Article
154—taking into account that Article 56 of Regulations of the General Health Law on
Health Research should be followed. In terms of section II of this article, creating an
embryowith the intention of later on enucleating it is prohibited.Thismeans that PNT
is prohibited when, during its procedure, an embryo is created for a non-reproductive
purpose, as is the case when an embryo is created with the sole intention of later
enucleating it.
Interestingly, not all instances of PNT are prohibited under section II. PNT prac-
tices are legally permitted in the State of Mexico City if the would-be-enucleated em-
bryos are first created for a reproductive purpose. For example, a couple going through
‘normal’ IVF could produce five embryos and end up with three surplus embryos if the
first cycle results in a child.This couple could later decide to donate their three surplus
embryos to a woman with an mtDNA disease who is considering PNT, supposing that
the embryos have been cryopreserved at the right moment for PNT to be carried out.
If doctors later enucleate these three embryos to carry out PNT, they would not violate
section II, since the enucleated embryos were originally created for a reproductive pur-
pose. Pointing out this caveat is important because we can now appreciate that in the
State ofMexico City PNT is not absolutely prohibited. Additionally, the State ofMexico
City does not protect life from the moment of conception or fertilization and does not
explicitly prohibit the destruction of early embryos (see Fig. 1).
In conclusion,Mexicohasno federal laws regulatinghumangenomemodificationor
human genetic engineering, and the international documents of whichMexico is signa-
tory donot expressly prohibit humangenomemodificationor humangenetic engineer-
ing at the somatic or germline level. In the State of Mexico City, PNT is only prohib-
ited when would-be-enucleated eggs are intentionally created for a non-reproductive
purpose.
71 ASAMBLEA LEGISLATIVA DEL DISTRITO FEDERAL, CO´DIGO PENAL PARA EL DISTRITO FEDERAL (2002 as amended
to Sep. 10, 2013), http://www.fimevic.df.gob.mx/documentos/transparencia/codigo local/CPDF.pdf (ac-
cessed Oct. 15, 2016).
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CONCLUSION
Herewewill briefly present ourmain conclusions and then exploreMexico’s panorama
of MRTs after this important event. First, in Mexico no federal laws specifically pro-
hibit MRTs or regulate human genome modification or human genetic engineering.
Secondly, at the federal level, research on MRTs is only legal when it is conducted to
treat infertility that cannot otherwise be solved.Thus, under our interpretation of the law
and with the available information, Zhang’s team broke the Regulations of the General
Health Law on Health Research and probably also regulations relating to research on
human beings.Thirdly, PNT is prohibited in nine states due to laws protecting human
life from the moment of fertilization. In the state of Jalisco, the intentional destruction
of human embryos in vitro could be prosecuted under criminal charges as homicide,
and in the State of Mexico City PNT is prohibited when a would-be-enucleated em-
bryo is created for a non-reproductive end.
It is clear that Mexico needs laws at the federal and state level regulating assisted
reproduction, in order to provide legal certainty about the obligations and rights of all
the parties involved in it. It is also clear that laws concerning human genome modi-
fication and human genetic engineering are needed at both levels, in order to tackle
the challenges that biotechnology offers. It could be thought that Zhang’s team’s
actions might have prompted an informed public discussion among Mexican politi-
cians, academics, stakeholders, and lay people regarding the paramount importance
of moving toward scientifically sound and well-considered laws on both issues. How-
ever, the reality is otherwise. In order to understandwhat has happened inMexico after
Zhang’s team’s feat, we must take a step back.
Before the news broke on the first use of MST in a human reproductive setting,
amendments relating to assisted reproduction to the General Health Law were be-
ing discussed in the Mexican Congress. The proposed amendments that seem more
likely to pass are very restrictive (eg prohibiting surrogacy for same-sex couples or sin-
gle persons), and scientifically problematic not only for assisted reproduction but also
for other biological research areas (eg hybrid or chimera research).72 Academics, stake-
holders, and NGOs had all raised concerns about these amendments and there is an
ongoing public debate about them and the need for them to be rejected.73
Since Zhang’s feat, conservative politicians have claimed that while the amendments
they propose are ‘perfectible’ it is better at this time to enact them rather than to remain
72 SYLVANA BELTRONES SA´NCHEZ, INICIATIVA QUE REFORMA Y ADICIONA DIVERSAS DISPOSICIONES DE
LA LEY GENERAL DE SALUD, A CARGO DE LA DIPUTADA SYLVANA BELTRONES SA´NCHEZ, DEL
GRUPO PARLAMENTARIO DEL PRI (2016), http://gaceta.diputados.gob.mx/Black/Gaceta/Anteriores/
63/2016/mar/20160301-IV/Iniciativa-12.html (accessed Oct. 15, 2016); Reardon, supra note 45; Palacios-
Gonza´lez, supra note 45.
73 He´ctor A. Mendoza C., 10 Argumentos Sobre la Ignorancia Legislativa, ANIMAL POL´ITICO, Oct. 12, 2016,
http://www.animalpolitico.com/blogueros-una-vida-examinada-reflexiones-bioeticas/2016/10/12/10-
argumentos-la-ignorancia-legislativa/ (accessed Oct. 26, 2016); Katia D’Artigues Beauregard, Maternidad
Discriminatoria Gracias Presidenciales, EL UNIVERSAL, Oct. 12, 2016, http://www.eluniversal.com.mx/
entrada-de-opinion/columna/katia-dartigues/nacion/2016/10/12/maternidad-discriminatoria-gracias
(accessed Oct. 17, 2016); Redaccio´n Animal Pol´ıtico, El Congreso Busca Restringir Acceso a Pare-
jas a la Reproduccio´n Asistida, ANIMAL POL´ITICO, Sept. 23, 2016, http://www.animalpolitico.com/
2016/09/ley-reproduccion-asistida-gestacion-subrogada/ (accessed Oct. 15, 2016); Reardon, supra
note 45.
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open to more experiments like Zhang’s taking place.74 Thus, Zhang’s team’s actions
have, unwittingly, helped the conservative cause make a stronger case for poorly con-
sidered legislation to be passed in a developing country.75 Further, and paradoxically,
Zhang’s team’s actions havehelped the case for passing legislation inMexico thatwould
legally prohibit MRTs, and which would certainly have economic effects on his fertil-
ity clinics in Mexico due to restrictions on who can access ARTs. In terms of research,
for example, Article 71 bis 6 of the proposed amendments asserts that the creation of
geneticallymodifiedembryos is prohibited; experimentationwithoronembryos is pro-
hibited; creation of embryos for non-reproductive ends is prohibited; transportation of
sperm, oocytes or embryos out of the country is prohibited; and any kind of selection
against disability is prohibited.76 It is clear that while the birth of the first post-MST
baby has prompted a discussion ofMRTs inMexico, it has also helped those who wish
to bar MRTs and related practices from happening in the country.
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